BFLY
Butterfly Network, Inc.3.3400
+0.1200+3.73%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Embedded pipeline, home care details emerge
Q&A amplified Butterfly Embedded details, revealing an 8-9 partner pipeline including giants, with Midjourney's $74M deal driving 2026-2027 revenue via licenses and milestones before chip sales kick in. Home care eyes H1 commercial pact for nominal 2026 revenue and up to $50M national opportunity by proving alt-site efficiencies. Macro concerns eased as deal cycles thaw despite mild tariffs. Medical schools set for Q2 surge. Embedded fuels core tech roadmap without distraction. Pipeline delivers real heat. Bullish tone persists; watch partner ramps.
Key Stats
Market Cap
843.69MP/E (TTM)
-Basic EPS (TTM)
-0.33Dividend Yield
0%Recent Filings
10-K
FY2025 results
Butterfly Network grew FY2025 revenue 19% y/y to $97.6M, with product sales up 17% to $63.4M on higher iQ3/iQ3 Vet probe volumes and Embedded chip deliveries, while software/services rose 23% to $34.2M via licensing deals. Yet Q4 momentum faltered as $17.4M excess inventory charge hammered gross margins to 46.9% from 59.5%, driving net loss wider to $77.1M. Embedded partnerships fueled recurring fees; cash hit $150.5M post-January raise. No annual guidance disclosed. Supply chain reliance on single vendors threatens quarterly output.
8-K
Record Q4 revenue surges 41%
8-K
NYSE delists BFLY warrants
NYSE notified Butterfly Network on January 13, 2026, to delist its BFLY WS warrants due to abnormally low selling prices, suspending trading immediately; warrants expire February 12, 2026, exercisable at $11.50 per Class A share. Common stock trading under BFLY continues unaffected on NYSE. Company views delisting as unrelated to performance.
8-K
Q4 revenue up 17%+ YoY
8-K
Licensing deal with Midjourney
Butterfly Network inked a co-development and licensing deal with Midjourney on November 17, 2025, granting exclusive access to its ultrasound-on-chip tech. Midjourney pays a $15 million upfront fee, $10 million annual license, up to $9 million in milestones, revenue sharing, and chip purchases. Five-year term. Deal bolsters non-dilutive revenue.
IPO
Employees
Sector
Industry
AIFF
Firefly Neuroscience, Inc.
1.41-0.06
BDMD
Baird Medical Investment Holdin
1.37+0.02
BDX
Becton, Dickinson and Company
196.39-3.70
BTCY
Biotricity Inc.
0.38+0.04
HTFL
Heartflow, Inc.
26.47+0.84
HYPR
Hyperfine, Inc.
0.95+0.02
MASI
Masimo Corporation
134.52-2.88
MDT
Medtronic plc.
97.72-0.85
QTIH
QT Imaging Holdings, Inc.
6.10-0.02
UTMD
Utah Medical Products, Inc.
58.43+0.94